with diminished expression of the tight junction protein occludin. LF control mice had essentially no evidence of BBB disturbances. Six months of SFA feeding exacerbated the difference in IgG abundance compared to the LF mice. At 12 months of feeding, the control LF mice also had significant parenchymal IgG that was comparable to mice fed the SFAor cholesterol-enriched diet for 3 months. However, there may have been an adaptation to the fat-enriched diets because SFA and cholesterol did not exacerbate IgG parenchymal accumulation beyond 6 months of feeding. Conclusion: Collectively, the study suggests that diets enriched in SFA or cholesterol accelerate the onset of BBB dysfunction that otherwise occurs with aging.
Introduction
The blood-brain barrier (BBB) is a fully differentiated neurovascular endothelial structure in the brain. The BBB consists of the tight junctions of vascular endothelial cells overlayed on basement membranes and has a critical function of excluding plasma-derived neurotoxic and inflammatory agents [1] . Several lines of evidence suggest that chronic disturbances of BBB function heighten neuronal inflammation and are likely to contribute to the progression of neurodegenerative disorders such as Alzheimer's disease (AD), vascular dementia (VaD), multiple sclerosis or Parkinson's disease [2, 3] . Indeed, in all these disorders, brain parenchymal extravasation of plasma proteins, perivascular gliosis and lacunar lesions are commonly reported, observations consistent with breakdown of the BBB [4] [5] [6] .
The risks for several neurodegenerative disorders including AD and VaD are influenced by lifestyle choices, including nutrition [7] [8] [9] . Population and clinical studies show a positive association of AD with dietary cholesterol and saturated fatty acids (SFA) [10, 11] , whereas both mono-and polyunsaturated fatty acids appear to confer protection against the risk of AD [12] [13] [14] . One mechanism for the association between dietary fats and AD may be via modulation of BBB function. In genetically unmanipulated mice, chronic ingestion of diets enriched with SFA or cholesterol, but not mono-or polyunsaturated fatty acids, attenuated the expression of endothelial tight junction proteins and resulted in parenchymal extravasation of plasma proteins, including circulating amyloid-␤ [15] . Ghribi et al. [16] made similar findings in wild-type rabbits maintained on cholesterol-supplemented diets and showed amyloid-like plaque pathology, and in amyloid transgenic mice, SFA/cholesterol-enriched diets were shown to significantly exacerbate cerebral amyloidosis [17, 18] .
Age is positively associated with the prevalence of dementia [19] . In the USA, 20% of the population older than 65 years and 50% of the population older than 80 years have probable AD or VaD. Several mechanisms could notionally explain the phenomenon of the 'ageinduced' increased risk for dementia, but these commonly describe chronically heightened states of systemic inflammation induced by comorbidities such as diabetes, cardiovascular disease and stroke or because of lifestyle behavior such as poor nutrition and being sedentary [3, 8] . In rodent models, otherwise healthy aged mice and rats maintained on diets containing just 4% of energy as fat and with little or no SFA/cholesterol nonetheless feature BBB abnormalities in comparison to younger animals [3, 20, 21] . The latter suggests independent but possibly synergistic effects with other comorbidities and vascular stressors. Accordingly, this study was designed to investigate BBB function in wild-type mice that were maintained on either a low-SFA and cholesterol-free diet or a diet enriched with either SFA or cholesterol for 3, 6 and 12 months.
Materials and Methods

Animals and Dietary Treatments
Six-week-old, female C57BL/6J mice were purchased from the Animal Resources Centre (Murdoch, W.A., Australia). Mice were kept in an accredited animal holding facility (Building 300, Curtin University) with a 12-hour light/dark cycle and controlled air temperature and pressure. Mice had ad libitum access to the feed and water.
Groups of 24 mice were randomly allocated to each dietary treatment group. A semisynthetic mice chow diet was provided by Specialty Feeds (Glenn Forrest, W.A., Australia). The control low-fat (LF) diet was the standard rodent chow AIN93M containing 4% (w/w) dietary fats as polyunsaturated oil and no cholesterol ( table 1 ) . The cholesterol-enriched diet was produced by adding 1% (w/w) cholesterol to the AIN93M control chow. An SFAenriched diet was prepared by adding 20% (w/w) SFA derived from cocoa butter. Digestible energy from the cocoa butter in the SFA diet was 40%, and the main fatty acids in the diet were pal- The detailed lipid composition of the diets used in this study. The control diet was AIN93M standard LF rodent chow containing no cholesterol and 4% unsaturated fats. The cholesterol diet contained 1% (w/w) sterol. The SFA diet contained 20% (w/w) SFA from cocoa butter. EPA = Eicosapentaenoic acid; DPA = docosapentaenoic acid; DHA = docosahexaenoic acid: n.d. = not detected; n.a. = not available. mitic (16: 0; 5%), stearic (18: 0; 7%) and oleic acid (18: 1 n-9; 6%; table 1 ). Eight mice from each group were sacrificed 3, 6 and 12 months after the commencement of dietary treatment, and brain and plasma samples were collected for analysis as described previously [15] .
All experimental procedures in this study were approved by a National Health and Medical Research Council of Australia-accredited animal ethics committee (Curtin University approval No. R08-10).
Quantitative Immunofluorescent Microscopy of Cerebral Immunoglobulin G Extravasation
The integrity of the BBB was determined by the detection of cerebral perivascular extravasation of the plasma protein immunoglobulin G (IgG). This is a widely used and established method [22, 23] , and in this study we used published quantitative 3-dimensional (3-D) immunomicroscopy methods described previously [8, 9, 15, [24] [25] [26] , with minor modifications. The right hemisphere of the brain was carefully isolated and washed in ice-cold PBS. The brain tissues were immersion-fixed in 4% paraformaldehyde for 24 h and cryoprotected in 20% sucrose for 3 days. The tissues were then frozen in isopentane/dry ice and stored at -80 ° C. Brain cryosections of 20 m were prepared on polysinecoated microscope slides, and the unspecific binding sites were blocked with 10% goat serum in PBS for 30 min. Goat antimouse IgG conjugated with Alexa 488 fluorochrome (Invitrogen, USA) was applied to the sections at a concentration of 1: 50 in PBS and incubated at 4 ° C for 20 h. After a thorough wash of the sections with PBS, 4 ,6-diamidino-2-phenylindole (DAPI) counterstaining (Invitrogen) was performed for nuclei detection, and the sections were mounted with antifade mounting medium.
The immunofluorescent micrographs were taken in 3-D with an AxioVert 200M (Carl-Zeiss, Germany) coupled with an mRM digital camera and ApoTome optical sectioning system. Each 3-D image was captured at a magnification of ! 200 (Plan-Neofluar 20 ! objective lens) and consisted of at least 12 2-dimensional Zstack images with a 1.225-m axial distance optimized by Nyquist theory. For each cortex and hippocampal formation regions, 5-12 3-D images were randomly taken from each brain section, and all the 3-D images were used for the subsequent quantitative analysis. Fluorescent voxel intensity of the IgG perivascular extravasation was calculated with Volocity 3-D image analysis software (PerkinElmer, UK) and expressed per volume unit.
Immunofluorescent Quantitative Analysis of the Cerebrovascular Tight Junction Protein Occludin-1
The abundance of the cerebrovascular tight junction protein occludin-1 relative to the endothelium was quantitatively determined in the cortex and hippocampus using 3-D double immunofluorescent microscopy as described previously [15, 24] . Briefly, the brain cryosections (20 m thick) were fixed with acetone at -20 ° C for 3 min, and heat-mediated antigen retrieval was conducted by incubating the sections in 60 ° C water for 2 h. Endogenous biotin was blocked with avidin in egg white and biotin in skimmed milk. In order to avoid the cross-reaction of the two polyclonal antibodies, the concentration of the first antibody was diluted so that it was undetectable with conventional secondary antibody detection but detectable after the biotin-avidin signal amplification. The sections were incubated with rabbit antimouse occludin-1 (1: 200; Invitrogen) for 20 h at 4 ° C after blocking of unspecific binding sites with 10% goat serum. The sections were then incubated with antirabbit IgG conjugated with biotin (1: 200; Dako) for 2 h at 20 ° C. Rabbit anti-von Willebrand factor (vWF; 1: 200; Abcam) was applied to the sections for 2 h at 20 ° C. Finally, the sections were incubated with a mixture of avidin conjugated with Alexa 546 and antirabbit IgG conjugated with Alexa 488. The nuclei were counterstained with DAPI. The colocalization of occludin-1 and vWF was determined, and the optical pixel intensity of occludin-1 in the colocalized area was calculated with AxioVision imaging software. The total vWF expression was also determined by calculating the voxel intensity with Volocity. The cerebrovascular expression of occludin-1 was expressed relative to the total vWF expression.
Immunofluorescent Analysis of Cerebral Glial Fibrillary Acidic Protein and Its Colocalization with Perivascular IgG Extravasation
Similar to cerebral IgG immunomicroscopy, the cortex and hippocampus expression of glial fibrillary acidic protein (GFAP) was determined as a surrogate marker for astrocyte activation by utilizing quantitative immunofluorescent microscopy. The brain cryosections were blocked with 10% goat serum and incubated with rabbit antimouse GFAP (1: 500; Abcam, UK) for 20 h at 4 ° C. Goat antirabbit IgG with Alexa 546 was then added to the section for 1 h, and the sections were counterstained with DAPI.
The colocalization of activated GFAP with the cerebral perivascular IgG leakage was also determined with double immunofluorescent staining. A mixture of goat antimouse IgG Alexa 488 and rabbit antimouse GFAP was applied to the sections and incubated for 20 h at 4 ° C. After a thorough wash, antirabbit IgG Alexa 546 was added to the sections and incubated for 1 h. The colocalization of the two proteins was analyzed by Volocity.
Determination of Plasma S100B S100B is a calcium-binding protein predominantly produced by astrocytes and abundant in cerebrospinal fluid but not in peripheral tissue or plasma [27] . Cerebrospinal fluid and/or plasma S100B is elevated in a number of neurodegenerative diseases including stroke and schizophrenia [28] [29] [30] . Therefore, the plasma concentration of S100B is often used as a marker of BBB integrity and cerebrovascular inflammation [27, 31, 32] . Plasma S100B was measured by an ELISA kit (CosmoBio, Japan) as per the instructions provided by the manufacturer. Briefly, 20 l of plasma samples or of the S100B standards (0, 98, 197, 394, 1,575, 3,150 and 6,300 pg/ml) were incubated overnight at 4 ° C in 96-well microplates coated with the primary antibody. Thereafter, plates were incubated with conjugated secondary antibody for 2 h, followed by 2 h of incubation with streptavidin-horseradish peroxidase. Finally, samples were incubated with substrate solution for 20 min, and the reaction was terminated with stopping solution. The optical absorbance was measured at 490 nm.
Plasma Lipid Assays
Plasma total cholesterol and triglycerides were determined with colorimetric assays (Randox, UK) according to the manufacturer's instructions with minor modifications. Briefly, 2 l of sample plasma or standard solution was added to a 96-well microplate, and 200 l of assay reagent was added. Samples were incubated for 5 min at 37 ° C, and the optical absorbance was measured at 500 nm. For cholesterol assay, the standard was plotted at 0, 1.25, 2.5 and 5.0 mmol/l. For triglycerides assay, the standard was plotted at 0, 1.1 and 2.19 mmol/l.
Statistics
For the quantitative immunomicroscopy, a minimum of 60 2-dimensional images were taken from each mouse and in total more than 480 images per group. For IgG extravasation, plasma S100B and cerebral GFAP, the cumulative effects through the entire experimental period were estimated by analyzing the area under the curve (AUC). The calculation of standard deviations for AUC was conducted according to the method of Bailer [33] . Oneway analysis of variance (ANOVA) followed by post hoc tests was used to determine the statistical significance (p ! 0.05; SPSS). For plasma lipid assays, the Pearson's correlation coefficient of plasma lipid level and BBB disruption (voxel intensity of IgG extravasation) was analyzed in each mouse using GraphPad Prism.
Results
The effect of aging and potential synergistic effects with diets enriched in either SFA or cholesterol on parenchymal extravasation of IgG is demonstrated in figure 1 and quantitatively compared in figure 2 for different durations of feeding. After 3 months of dietary intervention, there was limited IgG abundance within brain parenchyma in mice maintained on the LF control diet. However, in LF mice there was a 4-and 9-fold increase in plasmaderived IgG after 6 and 12 months of dietary intervention, respectively ( fig. 2 a) .
We confirm that mice maintained on a diet supplemented with cholesterol or enriched with SFA for 3 months had substantially greater parenchymal IgG abundance than control mice on the LF diet ( fig. 2 a) . However, interactive effects with age became evident, particularly in mice maintained on the SFA-enriched diet. Expressed as the cumulative index of IgG abundance (i.e. AUC between 3 and 12 months of feeding; CIG AUC ), mice maintained on an SFA-enriched diet had a 3-fold greater rate of IgG accumulation than the LF control group ( fig. 2 b) . Cholesterol-supplemented mice, like the SFA-fed mice, had an earlier onset of parenchymal accumulation of IgG compared to LF controls, with significant divergence between the two groups at 3 months. However, after 12 months of dietary intervention, the two groups showed similar levels of parenchymal IgG abundance. Indeed, there was no difference in CIG AUC after 12 months of feeding for the cholesterol-supplemented versus LF control mice ( fig. 2 b) .
Brain-to-blood leakage of S100B mirrored the significant differential effects of aging and dietary SFA/cholesterol on BBB integrity. Mice maintained on the LF diet showed a remarkable increase in plasma S100B after 12 months of dietary intervention compared to 3 months ( fig. 3 a) . Similarly, the SFA-or dietary cholesterol-supplemented mice had marked elevations in plasma S100B after 3 months of feeding. The cumulative plasma index of S100B was significantly increased in the SFA-fed mice ( fig. 3 b) , but there was no difference between cholesterolfed mice and LF controls. Concomitant with increased plasma S100B and parenchymal abundance of IgG was a significant reduction in the endothelium abundance of the tight junction protein occludin-1 ( fig. 4 ) .
To explore if disturbances in BBB function induced by aging and accelerated onset due to dietary SFA or cholesterol were associated with cerebrovascular inflammation, we determined the abundance of GFAP and its putative colocalization with parenchymal IgG accumulation to assess the activation of cerebral astroglial cells. Figure  5 shows the exaggerated abundance of GFAP and significant colocalization with IgG in LF control mice after 12 months of dietary intervention. The GFAP/IgG association was also evident in the SFA-fed mice and cholesterolfed mice (not shown). Consistently, Pearson's correlation coefficient analysis showed a significant correlation (p ! 0.0001) between the cerebral GFAP expression and IgG association in all groups ( fig. 6 c) . The expression of GFAP in the cortex was greater in SFA-and cholesterol-supplemented mice after 3 months of dietary intervention, but there was no significant difference between the groups at 12 months ( fig. 6 a) . An accelerated inflammatory onset associated with SFA feeding is suggested by the cumulative index of cortex GFAP, which was greater in the SFAfed mice compared to LF controls.
Plasma lipids were determined to explore if there was an association with the parenchymal appearance of IgG in aged and SFA/cholesterol-supplemented mice. The diets given to mice were well tolerated, and similar rates of weight gain were observed in all groups of mice (data not shown). The SFA-fed mice were hypertriglyceridemic after 3 months of feeding compared to LF control mice, but there was no difference between the groups of mice after 12 months of intervention ( fig. 7 c) . In contrast, mice maintained on cholesterol became hypercholesterolemic, and the divergence compared to the LF control group increased with age ( fig. 7 a) . Correlation analysis found no association of plasma triglyceride concentration and cerebral IgG extravasation ( fig. 7 d) . In contrast, there was a modest but nonetheless statistically significant association between plasma cholesterol and parenchymal IgG ( fig. 7 b) . 
Discussion
An accumulating body of evidence suggests that dysfunction of the BBB followed by blood-to-brain leakage of plasma neuroinflammatory substances may be important in the onset and progression of neurodegenerative disorders, including AD and VaD. Some studies suggest that disruption of the BBB occurs with normal aging; however, this hypothesis may be confounded because of comorbidities that develop with age or persistent poor lifestyle choices including dietary behavior. To explore the concept of an age-induced effect on BBB function and synergistic effects with dietary fats, in this study, a wildtype mouse model was used to examine whether BBB disruption develops in aging mice maintained on an LF and cholesterol-free diet and whether this is influenced by diets enriched in SFA or cholesterol.
The blood-to-brain leakage of the plasma protein IgG (150 kDa) is a commonly used approach to assess BBB integrity and function [16, 22, 23] . In this study, we used an established, highly sensitive immunofluorescent microscopy procedure to quantitatively assess the parenchymal abundance of IgG [15, 24] . In addition, colocalization analysis with a specific marker of cerebrovascular inflammation (GFAP) was carried out in 3 dimensions.
Consistent with previous studies [15] , we confirm the significant parenchymal abundance of IgG in mice maintained on an SFA-or cholesterol-rich diet for 3 months. However, there was no evidence that this occurred in mice maintained on an LF and cholesterol-free diet for 3 months. Accumulation of parenchymal IgG occurred concomitantly with a significant reduction in the endothelial tight junction protein occludin-1, consistent with disturbed BBB function. We extend those findings and now demonstrate that parenchymal extravasation of IgG progressively increases in aging mice maintained on what is considered a balanced LF diet. Indeed, there was a strong association of IgG extravasation and age, with substantially greater IgG after 12 months of dietary intervention compared to 6 months. Confirmation of an age-induced effect was also supported by findings of the plasma concentration of the neuronal peptide S100B. Mice maintained on the LF diet had significantly greater plasma S100B after 12 months of dietary intervention compared to 6 months and 3 months. Collectively, the data suggest that BBB function becomes progressively compromised with age, resulting in bidirectional and probably nonspecific trafficking of proteins that are normally otherwise excluded. Given that the average life span of genetically unmanipulated laboratory mice is 18-20 months, the findings suggest that the phenomenon of plasma-derived protein extravasation commences at approximately 'middle age'.
Concomitant with parenchymal IgG extravasation in LF control mice was evidence of cerebrovascular-specif- ic inflammation equivocally demonstrated by increased expression of GFAP after 6 and 12 months of dietary intervention. Moreover, there was significant colocalization of glial cell activation (indicated by GFAP) with IgG parenchymal penetration, consistent with a causal effect. Up to 6 months of dietary intervention, the data indicate that there may have been a synergistic effect of SFA with age, because divergence in the rate of IgG extravasation was observed between the two groups of mice (i.e. the difference between the two groups continued to increase between 3 and 6 months of dietary intervention). However, beyond 6 months, SFA feeding did not appear to exacerbate BBB dysfunction compared to the effects of aging alone. The earlier onset and accelerated induction response because of SFA feeding is supported by the finding of a substantially greater CIG AUC in the SFA group compared to aged LF mice. However, we cannot determine from this study whether introduction of SFA in perhaps already aged mice with established BBB dysfunction will have an additive effect on deterioration.
Like the SFA-fed mice, mice maintained on a diet containing an additional 1% of cholesterol by weight had accelerated onset of IgG accumulation within brain parenchyma compared to LF mice. However, the differential effect induced by dietary cholesterol was no longer evident after 6 or 12 months of intervention. Following 6 months of feeding, the IgG extravasation was not significantly different to the LF control group, and neither was there any difference in the CIG AUC or the cumulative plasma index of S100B.
Collectively, the finding that neither dietary SFA nor cholesterol continues to exacerbate parenchymal extravasation of IgG beyond 6 months of intervention suggests either an adaptation response to the fat-enriched diets or perhaps a submaximal effect. The former is more likely given the persistent difference between the 12 months of SFA feeding versus either the cholesterol-fed or LF control groups of mice.
Several mechanisms could explain the accelerated onset phenomenon observed in SFA-and cholesterol-supplemented mice; however, the reason for IgG extravasa- tion in LF control mice at an older age is less obvious. Lipotoxicity is a term used for a process that leads to end organ damage caused by excessive cellular lipid overload. Morgan [34] suggests that the underlying toxicity of SFA is a consequence of disturbances in protein processing and endoplasmic reticulum (ER) dysfunction, for example apoptotic induction. One relevant example was a study by Patil et al. [35] , who found that dietary palmitic acid induced region-specific cerebral damage because of higher fatty acid-metabolizing capacity of cortical astroglia. Conversely, cell culture studies suggest that incubation with longer-chain unsaturates has an antagonistic effect on stress pathways [36] . Similarly, Yao and Tabas [37] suggest that excess cholesterol causes ER and mitochondrial stress that can lead to apoptosis. Mitochondrial activity or lysosomal processing can result in the production of oxidized lipids, including cholesterol. A number of studies support the contention that oxidized lipids compromise tissue integrity and exacerbate inflammatory pathways [38, 39] . However, if mitochondrial and ER stress are central to the effects of SFA and cholesterol, it is unclear how the effects would become mitigated with increased duration of feeding. The data in this study showed a significant increase in plasma cholesterol in cholesterol-fed mice, but there was only a weak positive association with BBB dysfunction. The SFA-supplemented mice showed no changes in plasma cholesterol and triglyceride. Hence, we cannot completely rule out an effect of dyslipidemia.
Alternative explanations for BBB dysfunction with aging that are independent of comorbidities or other obvious lifestyle-related factors are relatively few. Repetitive hypoxic episodes were proposed to compromise capillary integrity either directly or because of diminished vascular endothelial growth factor-mediated angiogenesis following hypoxic episodes (which tend to increase with age) [40] [41] [42] [43] [44] . Alternatively, what we ordinarily consider to be complete, balanced or otherwise healthy diets may in a chronic context be subtly inadequate or deficient. Another explanation is that transient episodes of inflammation in response to infection or injury, transient metabolic disturbances or acute ingestion of proinflammatory compounds may provide repeated insults that are physiologically important but difficult to monitor [4] . In this study, mice were closely assessed for infection or disease by utilizing sentinel mice maintained within the same facility, but we did not identify any periods of infection with micro-organisms. On the other hand, the diet was not altered for the duration of the study, and so nutrient insufficiency or other dietary pro- inflammatory components cannot be ruled out. Finally, only modest environmental enrichment was provided (limited to 'hide boxes'), which may have resulted in stress-related effects.
In conclusion, this study for the first time quantitatively demonstrated a progressive decline in BBB function as a consequence of aging in genetically unmanipulated mice maintained on an LF and cholesterol-free diet. Early introduction of diets enriched in SFA or cholesterol was found to accelerate the onset of BBB dysfunction that occurs with aging. Dietary SFA but not cholesterol had a synergistic effect with aging on the degree of BBB dysfunction over the first 6 months of feeding, which persisted in mice after 12 months of dietary intervention. These data are informative in the context of the risk for neurodegenerative disorders that feature cerebrovascular disturbances. 
